Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.Lung Cancer (Amsterdam, Netherlands)|April 17, 2026
Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trialFabrice Barlesi, Jin Seok Ahn, Benjamin J Solomon, et al.Annals of Surgery|February 19, 2021
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter StudyXufeng Guo, Zhexin Wang, Hong Yang, et al.JAMA Surgery|June 23, 2021
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical TrialHong Yang, Hui Liu, Yuping Chen, et al.Annals of Surgery|December 20, 2019
Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter StudyXuefeng Leng, Wenwu He, Hong Yang, et al.Journal of Medicinal Chemistry|September 28, 2017
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)Xianfeng Li, Vincent Hernandez, Fernando L Rock, et al.The New England Journal of Medicine|April 10, 2024
Alectinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung CancerYi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, et al.Nature Communications|May 27, 2017
Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterationsJiang Chang, Wenle Tan, Zhiqiang Ling, et al.The Journal of Thoracic and Cardiovascular Surgery|September 22, 2022
Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010Dong Chen, Min Kong, Jiajing Sun, et al.Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.Pageof 16